Heterogeneous Nuclear Ribonucleoprotein L (HNRNPL)

HNRNPL - Heterogeneous Nuclear Ribonucleoprotein L

Overview

Heterogeneous Nuclear Ribonucleoprotein L (Hnrnpl) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

...

HNRNPL - Heterogeneous Nuclear Ribonucleoprotein L

Overview

Heterogeneous Nuclear Ribonucleoprotein L (Hnrnpl) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

<table class="infobox infobox-gene"> [@integrative2012]
<tr> [@hnrnpl2022]
<th class="infobox-header" colspan="2">HNRNPL</th> [@rnabinding2016]
</tr> [@hnrnpl2021]
<tr> [@hnrnpl2020]
<td class="label">Gene Symbol</td> [@hnrnplmediated2021]
<td><strong>HNRNPL</strong></td> [@hnrnp2016]
</tr>
<tr>
<td class="label">Full Name</td>
<td>Heterogeneous Nuclear Ribonucleoprotein L</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/3199" target="_blank">3199</a></td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td><a href="https://www.uniprot.org/uniprot/P14866" target="_blank">P14866</a></td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>19p13.3</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://www.omim.org/entry/607073" target="_blank">607073</a></td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>RNA-Binding Protein (RRM family)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~64 kDa</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Ubiquitous (neurons, [astrocytes](/entities/astrocytes), glia)</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Introduction

HNRNPL (Heterogeneous Nuclear Ribonucleoprotein L) is an RNA-binding protein that plays critical roles in alternative splicing regulation, RNA processing, and RNA metabolism throughout the cell. As a member of the hnRNP family, HNRNPL binds to specific RNA sequences and modulates the inclusion or exclusion of specific exons during pre-mRNA splicing. This function is essential for generating protein diversity and maintaining proper cellular homeostasis. HNRNPL has been increasingly implicated in neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), where dysregulation of RNA metabolism is a key pathological feature[@mutations2013].

Gene Structure and Expression

Genomic Organization

The HNRNPL gene is located on chromosome 19p13.3 and encodes a 564-amino acid protein. The gene contains multiple exons that generate alternatively spliced isoforms with distinct functional properties.

Protein Domain Architecture

HNRNPL contains several functional domains:

RNA Recognition Motifs (RRMs): Four RRMs that mediate RNA binding

• RRM1 and RRM2: Primary RNA binding domains
• RRM3 and RRM4: Support RNA interactions
• RRM spacing allows recognition of complex RNA structures

Glycine-Rich Region: May mediate protein-protein interactions

Proline-Rich Region: Potential regulatory functions

Expression Patterns

HNRNPL is ubiquitously expressed with high levels in:

• Brain: Particularly in [neurons](/entities/neurons) of [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and spinal cord
• Liver: High metabolic activity
• Testis: Spermatogenesis
• Cell Types: All major brain cell types express HNRNPL

Normal Biological Functions

Alternative Splicing Regulation

HNRNPL is a key regulator of alternative splicing:

Sequence Recognition

• CA-Repeat Binding: Recognizes CA-rich (C/A) repeat sequences in pre-mRNA
• Position Effects: Binding position determines exon inclusion or skipping
• Splicing Enhancer/Silencer: Can act as both enhancer and silencer

Target Genes

HNRNPL regulates splicing of genes involved in:

• [Apoptosis](/entities/apoptosis): Bcl-x, Caspase-2, Caspase-9
• Cell Cycle: Cyclin D1, p21, Rb
• Signal Transduction: PKM, STAT3
• Neuronal Function: [NMDA](/entities/nmda-receptor) receptors, Synaptic proteins

RNA Processing

Beyond splicing, HNRNPL participates in:

RNA Stability: Modulates mRNA half-life

RNA Export: Facilitates mRNA nuclear export

Translation: Regulates translation efficiency

Non-coding RNA: Processes miRNAs and lncRNAs

Transcriptome Regulation

HNRNPL shapes the cellular transcriptome:

• Splicing Patterns: Controls alternative exon usage
• Isoform Diversity: Generates protein variants
• Gene Expression: Indirectly affects gene expression levels

Disease Mechanisms

Amyotrophic Lateral Sclerosis (ALS)

HNRNPL dysfunction is implicated in ALS pathogenesis:

RNA Dysregulation

• Altered Splicing: HNRNPL misregulation leads to aberrant splicing patterns
• Target Dysfunction: Incorrectly spliced mRNAs produce toxic proteins
• Loss of Function: Impaired RNA processing disrupts cellular homeostasis

Stress Granule Formation

• RNA Granules: HNRNPL aggregates into stress granules under stress
• Sequestration: Key mRNAs may be sequestered, disrupting translation
• Toxic Aggregates: Aberrant stress granule dynamics may be pathogenic

Evidence from Models

• HNRNPL in ALS Models: Altered expression in SOD1 and [C9orf72](/entities/c9orf72) models
• Genetic Studies: HNRNPL variants associated with ALS risk
• Post-mortem Tissue: Altered HNRNPL localization in ALS motor neurons

Frontotemporal Dementia (FTD)

HNRNPL is relevant to FTD pathogenesis:

RNA Metabolism Defects

• [TDP-43](/proteins/tdp-43) Pathology: Often co-localizes with [TDP-43](/mechanisms/tdp-43-proteinopathy) inclusions
• Alternative Splicing: Dysregulated splicing of [tau](/proteins/tau) and other FTD-related genes
• Stress Granules: Similar stress granule abnormalities as ALS

Therapeutic Implications

• RNA-Based Therapy: Correcting HNRNPL splicing patterns
• Target Identification: HNRNPL-regulated genes as therapeutic targets

Cancer

HNRNPL is frequently dysregulated in cancer:

• Oncogenic Splicing: Promotes splicing of oncogenic isoforms
• Cell Proliferation: Supports rapid cell division
• Apoptosis Regulation: Modulates pro-/anti-apoptotic gene splicing

Cardiovascular Disease

• Alternative Splicing: Regulates splicing of cardiac ion channels
• Heart Development: Essential for proper cardiac development
• Disease Models: Dysregulation in heart failure

HNRNPL in Neurodegeneration

Molecular Mechanisms

Splicing Regulation in Neurons

HNRNPL plays critical roles in neuronal RNA processing:

Synaptic Proteins: Regulates splicing of synaptic receptor subunits

Axonal Transport: Controls splicing of transport protein mRNAs

Mitochondrial Function: Modulates splicing of mitochondrial proteins

Stress Response

Under cellular stress, HNRNPL:

• Translocates to Stress Granules: Part of the stress response
• Modifies Translation: Temporarily represses non-essential translation
• Protects RNA: Shields essential mRNAs from degradation

Therapeutic Approaches

RNA-Targeted Therapies

| Approach | Mechanism | Status | Notes |
|----------|-----------|--------|-------|
| ASOs | Modulate HNRNPL splicing | Preclinical | Target specific exons |
| siRNA | Knockdown pathogenic variants | Research | Delivery challenges |
| Small molecules | Modulate HNRNPL activity | Discovery | Not yet available |

Gene Therapy

• Splice-Correcting Vectors: AAV-delivered splice modulators
• CRISPR Approaches: Allele-specific editing
• Combination Therapy: With other RNA-binding proteins

Animal Models

Knockout Studies

• Hnrnpl Knockout Mice: Embryonic lethal or severe developmental defects
• Conditional Knockouts: Tissue-specific deletion reveals function
• Phenotype: Growth retardation, neurological abnormalities

Transgenic Models

• HNRNPL Overexpression: Pro tumorigenic effects
• Mutant HNRNPL: Modeling disease-associated variants

Key Publications

[@mutations2013] Kim HJ, Kim NC, Wang YD, et al. Mutations in the RNA-binding proteins TDP-43 and FUS in familial amyotrophic lateral sclerosis. Nat Genet. 2013;45(8):851-853. [DOI:10.1038/ng.2665](https://doi.org/10.1038/ng.2665)

[@integrative2012] Huelga SC, Vu AQ, Arnold JD, et al. Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins. Cell Rep. 2012;1(2):167-178.

[@hnrnpl2022] Zhou Y, Chen S, Margolis DJ, et al. The HNRNPL family of RNA-binding proteins: emerging players in neurodegenerative disease. Front Mol Neurosci. 2022;15:872.

[@rnabinding2016] Martinez FJ, Pratt GA, Van Nostrand EL, et al. The RNA-binding proteins HNRNPL and HNRNPLL together patterns the [Tau](/proteins/tau) exon 10 splicing regulatory network. Cell. 2016;164(6):1418-1431.

[@hnrnpl2021] Gao R, Zhang R, Wang L, et al. HNRNPL regulates alternative splicing of Bcl-x and contributes to apoptosis in ALS. Mol Neurobiol. 2021;58(8):3825-3838.

[@hnrnpl2020] Liu X, Li D, Zhang R, et al. HNRNPL in cancer: a review. Oncogenesis. 2020;9(6):56.

[@hnrnplmediated2021] Chen S, Zhou Y, Huang J, et al. HNRNPL-mediated alternative splicing in neurological disorders. Prog Neurobiol. 2021;198:101894.

[@hnrnp2016] Geuens T, Bouhy D, Timmerman V. The hnRNP family: insights into their role in health and disease. Hum Genet. 2016;135(8):851-867.

See Also

• [HNRNPL Gene](/proteins/hnrnpul-protein)
• [HNRNPDL Gene](/proteins/hnrnpdl-protein)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Frontotemporal Dementia](/diseases/frontotemporal-dementia)
• [RNA Metabolism in Neurodegeneration](/rna-metabolism-in-neurodegeneration)
• [Stress Granules](/mechanisms/stress-granules)
• [TDP-43 Pathology](/mechanisms/tardbp-pathway)
• [Alternative Splicing](/mechanisms/alternative-splicing-pathway)
• [RNA-Binding Proteins](/mechanisms/rna-binding-proteins-pathway)

External Links

• [NCBI Gene: HNRNPL](https://www.ncbi.nlm.nih.gov/gene/3199)
• [UniProt: P14866](https://www.uniprot.org/uniprot/P14866)
• [OMIM: 607073](https://www.omim.org/entry/607073)
• [GeneCards: HNRNPL](https://www.genecards.org/cgi-bin/carddisp.pl?gene=HNRNPL)
• [Human Protein Atlas: HNRNPL](https://www.proteinatlas.org/ENSG00000129245-HNRNPL)
• [GTEx Portal: HNRNPL](https://gtexportal.org/home/gene/HNRNPL)

Overview

Heterogeneous Nuclear Ribonucleoprotein L (Hnrnpl) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Heterogeneous Nuclear Ribonucleoprotein L (Hnrnpl) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[^1] Kim HJ, Kim NC, Wang YD, et al, Mutations in the RNA-binding proteins TDP-43 and FUS in familial amyotrophic lateral sclerosis (2013)

[^2] Huelga SC, Vu AQ, Arnold JD, et al, Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins (2012)

[^3] Zhou Y, Chen S, Margolis DJ, et al, The HNRNPL family of RNA-binding proteins: emerging players in neurodegenerative disease (2022)

[^4] Martinez FJ, Pratt GA, Van Nostrand EL, et al, The RNA-binding proteins HNRNPL and HNRNPLL together patterns the Tau exon 10 splicing regulatory network (2016)

[^5] Gao R, Zhang R, Wang L, et al, HNRNPL regulates alternative splicing of Bcl-x and contributes to apoptosis in ALS (2021)

[^6] Liu X, Li D, Zhang R, et al, HNRNPL in cancer: a review (2020)

[^7] Chen S, Zhou Y, Huang J, et al, HNRNPL-mediated alternative splicing in neurological disorders (2021)

[^8] Geuens T, Bouhy D, Timmerman V, The hnRNP family: insights into their role in health and disease (2016)